This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Seraj, M. J. Articles by Theodorescu, D. Search for Related Content PubMed PubMed Citation Articles by Seraj, M. J. Articles by Theodorescu, D.

Molecular Determination of Perivesical and Lymph Node Metastasis after Radical Cystectomy for Urothelial Carcinoma of the Bladder

Departments of Urology [M. J. S., A. R. T., D. T.] and Molecular Physiology and Biological Physics [D. T.], University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, and Division of Urology, Department of Surgery, University of Western Ontario, London, Ontario, Canada [J. L. C.]

Purpose: Current methods used to determine the pathological stage of the primary tumor and associated lymphatics after radical cystectomy are tedious, costly, and may lack the sensitivity afforded by molecular approaches such as reverse transcription-PCR (RT-PCR) for markers specific for urothelial tissue such as the uroplakin II (UPII) gene. Thus, we sought to evaluate an objective and sensitive molecular approach for the assessment of perivesical extension and lymph node status after radical cystectomy, based on the detection of UPII expression using RT-PCR and compare this assay to standard clinical and pathological examination.

Experimental Design: From November 1999 to September 2000, 27 patients with clinical T_a–T₃N₀M₀ urothelial bladder cancer underwent radical cystectomy, 19 (70%) of which also had pelvic lymphadenectomy. At the completion of cystectomy, systematic biopsies of the external surface of the bladder specimen as well as from the largest palpable lymph node found at lymphadenectomy were obtained for molecular analysis. RT-PCR analysis for UPII mRNA was carried out on these biopsy specimens, and results were compared with data obtained from conventional pathological examination.

Results: Pathologically organ-confined tumors had a 42% (5 of 12) incidence of positive signals in the perivesical tissues and 17% (1 of 7) in the lymph nodes. Corresponding percentages for pT_3aN₀ and pT_3b–T₄N₀ lesions were 67% (4 of 6)/25% (1 of 4) and 67% (4 of 6)/33% (2 of 6), respectively. Overall, pathologically node-negative cancers had a perivesical positivity rate of 54% (13 of 24) and a lymph node positivity rate of 25% (4 of 16). All patients with pathologically positive nodes had positive UPII signals in the lymph node sample.

Conclusions: This molecular assay aimed at assessing perivesical extension and lymph node status after radical cystectomy appears to identify patients that may harbor residual disease not appreciated by conventional histology. Larger studies with 5–7-year follow-up will be required to determine the prognostic significance of such molecular information.